NVDA's 11.9% YTD gain trails chip peers, but AI data center demand, the Blackwell ramp-up and a lower P/E keep the upside case alive, backed by strong quarterly results.
NVDA's 11.9% YTD gain trails chip peers, but AI data center demand, the Blackwell ramp-up and a lower P/E keep the upside case alive, backed by strong quarterly results.
NVDA's 11.9% YTD gain trails chip peers, but AI data center demand, the Blackwell ramp-up and a lower P/E keep the upside case alive, backed by strong quarterly results.
NVDA's 11.9% YTD gain trails chip peers, but AI data center demand, the Blackwell ramp-up and a lower P/E keep the upside case alive, backed by strong quarterly results.
Apple's stock declined almost 2% on the first day of Apple CEO Tim Cook's final Worldwide Developers Conference (WWDC). The reason was more perceived letdown on the artificial intelligence front, which reawakened chatter that Apple won't dominate in the AI era.
Apple's stock declined almost 2% on the first day of Apple CEO Tim Cook's final Worldwide Developers Conference (WWDC). The reason was more perceived letdown on the artificial intelligence front, which reawakened chatter that Apple won't dominate in the AI era.
A selloff on Friday whipsawed investors used to seeing momentum stocks go nowhere but up. They shouldn’t be quick to disregard it as a one-off. Such is the warning from trading desks at Barclays Plc and Goldman Sachs Group Inc., who say crowded positioning, narrow market breadth and the prospect of higher-for-longer interest rates make the stock market more vulnerable to abrupt pullbacks. “All of ...
A selloff on Friday whipsawed investors used to seeing momentum stocks go nowhere but up. They shouldn’t be quick to disregard it as a one-off. Such is the warning from trading desks at Barclays Plc and Goldman Sachs Group Inc., who say crowded positioning, narrow market breadth and the prospect of higher-for-longer interest rates make the stock market more vulnerable to abrupt pullbacks. “All of that creates an environment where factor unwinds can become materially more violent than index-level volatility implies,” Goldman traders including Lee Coppersmith wrote in a note to clients. Friday gave investors a taste of how quickly the tide may turn for the stock market’s biggest winners should sentiment flip. The iShares MSCI USA Momentum Factor ETF lost 6% that day in its sharpest decline since a ‘Liberation Day’ selloff in April 2025. The Nasdaq 100 Index fell 4.8% as traders rushed to dump megacap technology stocks and snap up defensive names. The momentum trade, which involves buying winners in the market and selling the losers, is more crowded on the long end than ever, data compiled by Goldman show. At the same time, the short end remains underowned, the data show, amplifying the risk of a sharp reversal should uncertainty take hold regarding the artificial intelligence trade, the Federal Reserve’s interest rate path or rekindling inflation. Systematic investors may add to the pressure. Commodity trading advisers and volatility-control strategies have ramped up stock exposure to the highest level since February, leaving them vulnerable to forced selling if price swings persist. Volatility-controlled funds may need to cut US stock allocation by roughly 14 percentage points following Friday’s rout, according to Barclays’ head of global equities tactical strategies Alexander Altmann . That would be the biggest one-day de-risking since Feb. 6. Some of the derisking likely happened on Friday, but much of the selling typically takes place with a short-term lag, which ...
The New York Knicks may have lost Game 3 of the NBA Finals, but they're still ahead by a game, and Wall Street has been cheering them on. Shares of Madison Square Garden Sports ( MSGS ), the parent company of the Knicks, have been on a rip since the team clinched a playoff spot in late March, soaring more than 20%. However, the real story here has taken place over the past year, with the stock mor...
The New York Knicks may have lost Game 3 of the NBA Finals, but they're still ahead by a game, and Wall Street has been cheering them on. Shares of Madison Square Garden Sports ( MSGS ), the parent company of the Knicks, have been on a rip since the team clinched a playoff spot in late March, soaring more than 20%. However, the real story here has taken place over the past year, with the stock more than doubling in value and beating many market benchmarks. Bing Bong! The factors boosting the share price go beyond the Knicks' championship, though the "first time since 1999" does make a good headline. Fans are increasingly prioritizing live events over digital consumption, seeking tangible and communal experiences that cannot be replicated by a screen. This is especially true among higher-earning consumers, who are continuing to shell out big bucks on live sports and concerts. This has all led to high-margin growth, with explosive premium ticket pricing power, especially with a crew like Jalen Brunson and Karl-Anthony Towns. It has also led to scaled value via sports franchise appreciation, sponsorship deals, rising media rights contracts, and merchandising revenue. MSG Sports ( MSGS ) gets further cuts from the in-game concessions and premium suite licensing sister company from Madison Square Garden Entertainment ( MSGE ), which has seen its stock nearly double over the past year. The success has spread to other James Dolan-controlled properties as well, with shares of Sphere Entertainment ( SPHR ) skyrocketing over 250% since last summer. Corporate structure: Madison Square Garden Sports ( MSGS ) owns both the Knicks and the Rangers, and a new proposal this year excited investors. The spinoff would divide the two teams into separately traded entities, helping to unlock further value typically hindered by holding company dynamics. "During 2025, MSGS stock had an average market cap of $5B vs. a combined team valuation of $11B trading at more than a 50% Dolan discount....
Over the last 7 days, the United States market has experienced a 2.7% drop, yet it has risen by 23% over the past year with earnings expected to grow by 17% annually. In this context, growth stocks with high insider ownership can offer unique insights into potential opportunities as insiders may have confidence in their company's future prospects and are often aligned with shareholder interests.
Over the last 7 days, the United States market has experienced a 2.7% drop, yet it has risen by 23% over the past year with earnings expected to grow by 17% annually. In this context, growth stocks with high insider ownership can offer unique insights into potential opportunities as insiders may have confidence in their company's future prospects and are often aligned with shareholder interests.
MotionIsland/iStock via Getty Images Co-authored by Luuk Wierenga. A massive supply shortage is coming, and no, I'm not talking about oil, fertilizer, aluminum, sulfur, or any of the other commodities that used to travel through the Strait of Hormuz. That is a possibility we have accounted for with other portfolio picks at High Dividend Opportunities , but today we want to focus on something more ...
MotionIsland/iStock via Getty Images Co-authored by Luuk Wierenga. A massive supply shortage is coming, and no, I'm not talking about oil, fertilizer, aluminum, sulfur, or any of the other commodities that used to travel through the Strait of Hormuz. That is a possibility we have accounted for with other portfolio picks at High Dividend Opportunities , but today we want to focus on something more local. The real estate construction cycle has been materially impacted by rapidly rising interest rates. High-interest rates caused many companies to pull back from investing in new construction because it made new construction more expensive and less profitable. The thing is that for many commercial structures, development is something that takes several years. There are zoning and other political considerations and processes that have to be gone through before a shovel even touches the ground. Then, even when construction starts, it is a process that can take a year or even several years, depending on the complexity and size of the project. What happens when you have several consecutive years when investors are disincentivized from embarking on development projects? The incoming supply of leasable space fails to keep up with demand. When demand is higher than supply, prices go up. REITs have seen their share prices decline in recent years because interest rates have gone up. Higher rates directly cause lower property values, and since REITs typically use leverage, it increases their cost of borrowing. Yet, the unseen benefit is that by discouraging activity in the real estate market, high rates also discourage new construction. Since development takes years to ramp up, this results in a lack of supply and causes prices to rise. Who owns the supply? REITs. Sector Opportunity: REIT CEFs When you invest in individual dividend stocks or funds, it is important to look at the broader sector trends. For a while now, we've been reading about a clear lack of new supply coming thro...
Pakistan has again pushed back the presentation of its annual budget, further extending an unusual delay that has prompted speculation from analysts and investors about its reasons. The federal budget, typically among the most predictable events in the country, will “likely” be presented on Friday, Pakistan’s Parliamentary Minister Dr. Tariq Fazal Chaudhary in a post on X. The budget had previousl...
Pakistan has again pushed back the presentation of its annual budget, further extending an unusual delay that has prompted speculation from analysts and investors about its reasons. The federal budget, typically among the most predictable events in the country, will “likely” be presented on Friday, Pakistan’s Parliamentary Minister Dr. Tariq Fazal Chaudhary in a post on X. The budget had previously been scheduled for Wednesday. Earlier, Pakistan Foreign Minister Ishaq Dar had told Bloomberg News it would be shared the first week of June. So far, the government hasn’t given any reason for the delay. On Monday, Planning Minister Ahsan Iqbal said a final decision on the budget date was pending as key measures remain unresolved, though he didn’t specify what they were. Pakistan’s information minister and an adviser to the finance minister didn’t immediately respond to a request for a comment. Delays in Pakistan’s budget presentation are rare. Mohammed Sohail, CEO at brokerage Topline Securities Ltd., said the delay could be due to disagreement over cost-sharing between the central and provincial governments. Pakistan’s budget is likely to come under added attention given the government’s need to stay aligned with commitments under its $7 billion International Monetary Fund program. The country has also come under fiscal strain following the war in Iran given its heavy dependence on Persian Gulf energy imports.
onurdongel/iStock via Getty Images Alterity Therapeutics ( ATHE ) and the FDA have reached on agreement on the details for the pharma' phase 3 program for ATH434, its candidate for the rare neurodegenerative disorder multiple system atrophy. The particulars include the study population, treatment duration, and primary endpoint, the 11-item UMSARS Part I rating scale. About 200 patients will enroll...
onurdongel/iStock via Getty Images Alterity Therapeutics ( ATHE ) and the FDA have reached on agreement on the details for the pharma' phase 3 program for ATH434, its candidate for the rare neurodegenerative disorder multiple system atrophy. The particulars include the study population, treatment duration, and primary endpoint, the 11-item UMSARS Part I rating scale. About 200 patients will enroll in the placebo-controlled trial. Alterity’s proposed Phase 3 dose regimen of ATH434 is 50 mg twice daily. In phase 2 at that dose, 48% of patients achieved slowing of disease progression vs placebo and efficacy based on the UMSARS Part I. Secondary endpoints include the Swallowing Disturbance Questionnaire, the Orthostatic Hypotension Symptom Assessment, and the Clinical Global Impression of Severity. According to Alterity, ATH434 is designed to redistribute excess iron and slow abnormal protein aggregation associated with neurodegeneration. Shares are down ~13% in premarket trading Tuesday. More on Alterity Therapeutics Alterity Therapeutics Limited (ATHE) Discusses Phase II Data and Development Strategy for ATH434 in Multiple System Atrophy - Slideshow Alterity Therapeutics Limited (ATHE) Discusses Phase II Data and Development Strategy for ATH434 in Multiple System Atrophy Transcript Seeking Alpha’s Quant Rating on Alterity Therapeutics Historical earnings data for Alterity Therapeutics Financial information for Alterity Therapeutics
Inflationary pressure, still-high interest rates and tariffs are major concerns for the Zacks Internet - Delivery Services industry. However, efforts to adopt consumer preferences and technological advancements are likely to help GDDY, VIPS and ASUR navigate the headwinds.
Inflationary pressure, still-high interest rates and tariffs are major concerns for the Zacks Internet - Delivery Services industry. However, efforts to adopt consumer preferences and technological advancements are likely to help GDDY, VIPS and ASUR navigate the headwinds.
Check out the companies making headlines before the bell: GSK , Nuvalent — Shares of U.S. drugmaker Nuvalent rose nearly 39% after U.K.-based biopharmaceutical company GSK announced an agreement to acquire the company for $10.6 billion. J.M. Smucker Company — Shares jumped 3.5% after the maker of Smucker's jam and Jif peanut butter reported fourth-quarter results that topped expectations. Earnings...
Check out the companies making headlines before the bell: GSK , Nuvalent — Shares of U.S. drugmaker Nuvalent rose nearly 39% after U.K.-based biopharmaceutical company GSK announced an agreement to acquire the company for $10.6 billion. J.M. Smucker Company — Shares jumped 3.5% after the maker of Smucker's jam and Jif peanut butter reported fourth-quarter results that topped expectations. Earnings of $2.77 per share, on an adjusted basis, exceeded the $2.64 FactSet consensus estimate. Revenue of $2.27 billion also topped the anticipated $2.26 billion. SailPoint —The identity, data and security intelligence platform plunged more than 12% after issuing lackluster full-year guidance, even as its first-quarter earnings exceeded estimates. SailPoint expects adjusted earnings of 30 cents to 34 cents for the full year ending January, while analysts polled by FactSet were anticipating 32 cents. Expected revenue of $1.265 billion to $1.275 billion for the full year came in the low range of the expected $1.27 billion. Alibaba — The Pentagon added a slew of Chinese companies, including Alibaba Group, Baidu Inc and carmaker BYD, to a list of entities it believes have aided the Chinese military. Shares of Alibaba gained 0.9%, while shares of Baidu climbed more than 1%. Vail Resorts — Shares of the mountain resort company dropped 4.9% after Vail Resorts posted disappointing earnings of $8.81 per share in the third quarter, missing the $8.96 LSEG consensus estimate. Revenues of $1.21 billion came in line with expectations. Chip stocks — Chip stocks continued their comeback in the premarket Tuesday, with the VanEck Semiconductor ETF gaining 1.8%. Shares of Micron Technology climbed 5%, while shares of Qualcomm were up by 2.6%. — CNBC's Anniek Bao and Davis Giangiulio contributed reporting